Invited Commentary: A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia

J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa509. doi: 10.1210/clinem/dgaa509.
No abstract available

Keywords: Congenital adrenal hyperplasia; clinical trial; nevanimibe; treatment.

Publication types

  • Comment

MeSH terms

  • 17-alpha-Hydroxyprogesterone
  • Adrenal Hyperplasia, Congenital* / drug therapy
  • Humans
  • Urea / analogs & derivatives

Substances

  • 17-alpha-Hydroxyprogesterone
  • Urea
  • nevanimibe